Ocugen Inc chart

Last update: 2022-12-30
Key statistics and financials
Revenue per share N/A
Dividend & YieldN/A$ (N/A)
Beta 3.99
Market capitalization 321.76M
Operating cash flow -55.97M
ESG Scores unknown

Company description

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

Sector: Healthcare - Industry: Biotechnology

Financial Ratios
Quick Ratio13.95
Working Capital-0.61
Return On Equity-0.61
Debt To Equity0.02
Fixed Asset Ratio3.68
Fixed Interest Cover-734.53

Financial data

Financial Statements

Cashflow Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Change To Liabilities 3.63M -1.63M -541k 3.5M
Total Cashflows From Investing Activities -77.41k -2.36M -307k -1.82M
Net Borrowings 7.29M 1.48M -4.73M -10k
Total Cash From Financing Activities 7.18M 25.07M 31.61M 120.68M
Change To Operating Activities -254.52k -1.48M -669k -1.01M
Issuance Of Stock 1.18M 1.18M 37.82M 129.21M
Net Income -18.22M -20.24M -21.82M -58.37M
Change In Cash -4.52M 5.82M 16.59M 70.92M
Effect Of Exchange Rate 451
Total Cash From Operating Activities -11.63M -16.89M -14.71M -47.94M
Depreciation 49.62k 61k 102k 229k
Change To Account Receivables
Other Cashflows From Financing Activities -103.92k 22.45M -1.48M -8.53M
Change To Netincome 3.16M 6.4M 8.22M 7.71M
Capital Expenditures -77.41k -30k -307k -1.07M

Income Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Research Development 10.32M
Income Before Tax -18.22M -20.24M -21.82M -58.42M
Net Income -18.22M -20.24M -21.82M -58.37M
Selling General Administrative 5.82M 6.08M 7.97M 22.92M
Gross Profit -8.09M -6.31M -35.11M
Ebit -16.14M -14.16M -14.29M -58.03M
Operating Income -16.14M -14.16M -14.29M -58.03M
Interest Expense -3.75M -1.77M -721k -79k
Income Tax Expense -52k
Total Revenue 43k
Cost Of Revenue 8.09M 6.35M 35.11M
Total Other Income ExpenseNet -2.08M -6.08M -7.54M -389k
Net Income From Continuing Ops -18.22M -20.24M -21.82M -58.37M
Net Income Applicable To Common Shares -18.22M -20.24M -34.37M -58.37M

Balance Sheet Statement 2018-12-31 2019-12-31 2020-12-31 2021-12-31
Total Liabilities 15.16M 5.79M 5.83M 9.94M
Total Stockholder Equity -12.71M 11.02M 21.55M 95.82M
Other Current Liabilities 1.95M 205.99k
Total Assets 2.45M 16.81M 27.38M 105.76M
Common Stock 49.61k 527.47k 1.84M 2M
Other Current Assets 7M
Retained Earnings -31.24M -51.48M -73.3M -131.67M
Treasury Stock 451 -47.86k -48k -48k
Cash 1.63M 7.44M 24.04M 94.96M
Total Current Liabilities 14.11M 4.54M 3.61M 7M
Other Stockholder Equity 451
Property, Plant, and Equipment 245.79k 567.04k 1.07M 2.75M
Total Current Assets 1.94M 15.77M 25.88M 102.65M
Net Tangible Assets -12.71M 11.02M 21.55M 95.82M
Net Receivables
Accounts Payable 3.28M 1.9M 395k 2.31M


Insider Transactions

Here are the insider transactions of stock shares related to Ocugen Inc:

Filer Name Transaction Text Ownership Date Filer Relation Shares
MUSUNURI SHANKAR PH.DSale at price 1.66 per share.D2022-10-14Chief Executive Officer100k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.51 per share.D2022-10-14Chief Executive Officer100k
KUMAR RAMESHSale at price 1.83 per share.D2022-10-06Director4.5k
KUMAR RAMESHConversion of Exercise of derivative security at price 0.51 per share.D2022-10-06Director4.5k
CASTILLO KIRSTENSale at price 2.91 per share.D2022-08-11Director42k
CASTILLO KIRSTENConversion of Exercise of derivative security at price 0.28 per share.D2022-08-11Director42k
KUMAR RAMESHSale at price 2.57 per share.D2022-07-18Director7.5k
KUMAR RAMESHConversion of Exercise of derivative security at price 0.51 per share.D2022-07-18Director7.5k
MUSUNURI SHANKAR PH.DSale at price 2.72 per share.D2022-07-14Chief Executive Officer150k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.33 per share.D2022-07-14Chief Executive Officer150k
MUSUNURI SHANKAR PH.DSale at price 1.92 per share.D2022-05-13Chief Executive Officer125k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.33 per share.D2022-05-13Chief Executive Officer125k
KUMAR RAMESHSale at price 2.83 per share.D2022-04-18Director7.5k
KUMAR RAMESHConversion of Exercise of derivative security at price 0.51 per share.D2022-04-18Director7.5k
CRESPO JESSICAStock Award(Grant) at price 0.00 per share.D2022-03-18Officer22.94k
MUSUNURI SHANKAR PH.DSale at price 2.65 per share.D2022-03-16Chief Executive Officer81.82k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.33 per share.D2022-03-16Chief Executive Officer81.82k
ZHANG JUNGEConversion of Exercise of derivative security at price 0.51 - 1.83 per share.D2022-03-03Director88k
MUSUNURI SHANKAR PH.DSale at price 3.74 per share.D2022-02-14Chief Executive Officer90k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.33 per share.D2022-02-14Chief Executive Officer90k
KUMAR RAMESHSale at price 4.07 per share.D2022-01-18Director7.5k
KUMAR RAMESHConversion of Exercise of derivative security at price 0.51 per share.D2022-01-18Director7.5k
SUBRAMANIAN SANJAYStock Award(Grant) at price 0.00 per share.D2022-01-03Chief Financial Officer125.53k
MUSUNURI SHANKAR PH.DStock Award(Grant) at price 0.00 per share.D2022-01-03Chief Executive Officer346.54k
MUSUNURI SHANKAR PH.DSale at price 5.22 per share.I2021-12-16Chief Executive Officer115k
POTTI MANISHConversion of Exercise of derivative security at price 0.51 - 1.83 per share.D2021-12-16Director45k
ZHANG JUNGEConversion of Exercise of derivative security at price 2.77 - 7.56 per share.I2021-11-16Director145.47k
MUSUNURI SHANKAR PH.DSale at price 8.04 per share.I2021-11-16Chief Executive Officer115k
ZHANG JUNGESale at price 12.73 per share.I2021-11-03Director150.3k
ZHANG JUNGESale at price 15.75 per share.I2021-11-02Director149.7k
KOMPELLA UDAY B.Sale at price 14.05 - 16.01 per share.I2021-11-02Director50k
POTTI MANISHSale at price 15.07 per share.I2021-11-02Director63.43k
CASTILLO KIRSTENSale at price 15.00 per share.D2021-11-02Director15k
MUSUNURI SHANKAR PH.DSale at price 14.15 per share.D2021-11-01Chief Executive Officer115.37k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.51 per share.D2021-11-01Chief Executive Officer115.37k
SUBRAMANIAN SANJAYSale at price 9.15 per share.D2021-10-26Chief Financial Officer10k
KOMPELLA UDAY B.Sale at price 9.08 - 9.15 per share.I2021-10-26Director71.37k
KOMPELLA UDAY B.Sale at price 9.01 per share.I2021-10-21Director1.9k
KOMPELLA UDAY B.Sale at price 8.41 - 9.02 per share.I2021-10-20Director201.73k
KUMAR RAMESHSale at price 8.13 per share.D2021-10-18Director7.5k
KUMAR RAMESHConversion of Exercise of derivative security at price 0.51 per share.D2021-10-18Director7.5k
SUBRAMANIAN SANJAYSale at price 9.96 per share.D2021-10-15Chief Financial Officer7.99k
SUBRAMANIAN SANJAYConversion of Exercise of derivative security at price 2.19 per share.D2021-10-15Chief Financial Officer7.99k
MUSUNURI SHANKAR PH.DSale at price 9.80 per share.D2021-10-15Chief Executive Officer125k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.33 per share.D2021-10-15Chief Executive Officer125k
MUSUNURI SHANKAR PH.DSale at price 7.52 per share.D2021-09-15Chief Executive Officer125k
MUSUNURI SHANKAR PH.DConversion of Exercise of derivative security at price 0.33 per share.D2021-09-15Chief Executive Officer125k
SUBRAMANIAN SANJAYSale at price 7.22 per share.D2021-08-16Chief Financial Officer30k
SUBRAMANIAN SANJAYConversion of Exercise of derivative security at price 0.34 per share.D2021-08-16Chief Financial Officer30k
KOMPELLA UDAY B.Sale at price 6.81 per share.D2021-07-30Director10k
KOMPELLA UDAY B.Conversion of Exercise of derivative security at price 1.83 per share.D2021-07-30Director10k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Ocugen Inc. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Ocugen Inc

Here is the result of two systematic investment strategies applied to Ocugen Inc. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Ocugen Inc

The following chart shows the equity curve of the two systematic investment strategies applied to Ocugen Inc:

Ocugen Inc automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 653.37% on the backtest period.

Performance at glance

Performance

653.37 %

Latent gain

15046.25 $

Invested capital

2302.87 $

Annualized return

157.82 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Ocugen Inc

This is the result of two momentum investment strategies applied to Ocugen Inc. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Ocugen Inc

The following chart shows all the entries opened by the momentum investment system on Ocugen Inc:

Ocugen Inc momentum entries
  • The first momentum investment strategy would give 720.08% of return on Ocugen Inc. That represents 35710.34$ of latent gain with 4959.19$ of employed capital.
  • The second momentum investment strategy would give 704.35% of return on Ocugen Inc. That represents 28445.81$ of latent gain with 4038.61$ of employed capital.
Performance at glance (1Q Momentum)

Performance

720.08 %

Latent gain

35710.34 $

Invested capital

4959.19 $

Annualized return

0.0 %
Performance at glance (2Q Momentum)

Performance

704.35 %

Latent gain

28445.81 $

Invested capital

4038.61 $

Annualized return

192.45 %

Momentum equity curve on Ocugen Inc

The following chart shows the equity curve of the two momentum strategies applied to Ocugen Inc:

Ocugen Inc momentum equity

Note: the dividends potentially given by Ocugen Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Ocugen Inc

The following chart shows the employed capital evolution of the two momentum strategies on Ocugen Inc since the beginning:

Ocugen Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Buy the dip strategy result on Ocugen Inc

Buy the dip entry openings on Ocugen Inc

Ocugen Inc

The performance achieved by the robo-advisor on Ocugen Inc is 0%. That represents 0.0$ of latent gain with 0.0$ of employed capital. The following chart shows Ocugen Inc stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Ocugen Inc, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 $

Invested capital

0.0 $

Annualized return

0.0 %

Equity curve of the strategy applied to Ocugen Inc

The following chart shows the result of the investment strategy applied to Ocugen Inc:

Ocugen Inc

Note: the dividends potentially given by Ocugen Inc are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Ocugen Inc

The following chart shows the employed capital evolution since the beginning of the investment strategy on Ocugen Inc:

Ocugen Inc

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Ocugen Inc

In this section, I will compare the three previous investment strategies applied to Ocugen Inc.

Equity curve comparison on Ocugen Inc

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Ocugen Inc investment strategy comparison

Employed capital comparison on Ocugen Inc

Ocugen Inc investment comparison

Performance comparison on Ocugen Inc

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 653.37% 15046.25$ 2302.87$ 157.82%
Momentum 1 quarter 720.08% 35710.34$ 4959.19$ 184.64%
Momentum 2 quarters 704.35% 28445.81$ 4038.61$ 192.45%
Non-directional 0% 0.0$ 0.0$ 0.0%
Annualized return comparison

Automatic investment

157.82 %

Momentum 1Q

192.45 %

Momentum 2Q

192.45 %

Non-directional

0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Ocugen Inc:

Positive correlations

Most correlated stocks this year

  • Ocugen Inc

  • Most correlated stocks last 3 months

  • Seadrill Ltd
  • MIE HOLDINGS
  • Ocugen Inc
  • SPDR Portfolio TIPS ETF

  • Negative correlation

    Most negatively correlated stocks this year


    Most negatively correlated stocks last 3 months


    Note: The algorithm computes the probability of correlation between Ocugen Inc and the other stocks. There may be false positives or some missing correlated stocks. If the price of Ocugen Inc does not vary for 36 weeks, the correlation calculation result will be wrong.


    Company information

    Company name Ocugen Inc
    Country United States
    City Malvern
    Address 263 Great Valley Parkway
    Phone 484 328 4701
    Website www.ocugen.com
    FullTime employees 56
    Industry Biotechnology
    Sector Healthcare
    Exchange XNAS
    Ticker OCGN
    Market www.nasdaq.com

    Ocugen Inc ESG Scores

    Environment scores

    Environment ESG Factors Scores
    Environment Score 0
    Peer Environment Performance unknown
    Environment Percentile unknown
    Palm Oil unknown
    Nuclear unknown
    Fur Leather unknown
    GMO unknown
    Coal unknown
    Pesticides unknown
    Animal Testing unknown

    Social scores

    Social ESG Factors Scores
    Social Score 0
    Peer Social Performance unknown
    Social Percentile unknown
    Highest Controversy unknown
    Peer Highest Controversy Performance unknown
    Adult unknown
    Gambling unknown
    Alcoholic unknown
    Tobacco unknown
    Catholic unknown
    Controversial Weapons unknown
    Small Arms unknown
    Military Contract unknown
    Peer Count unknown

    Related Controversy:


    Governance scores

    Governance ESG Factors Scores
    Governance Score 0
    Peer Governance Performance unknown
    Governance Percentile unknown

    ESG at glance
    Total ESG Scores: unknown
    Environment Score: 0
    Social Score: 0
    Governance Score: 0

    ESG Performance: unknown

    Peer Group: unknown

    Peer Esg Score Performance: unknown

    Rating Year: unknown

    Rating Month: unknown

    Max Age: unknown

    Percentile: unknown